The ALPS Medical Breakthroughs ETF (SBIO) rallied 3.66% last week, outpacing competing biotech ETFs and major U.S. indexes. The biotech sector was propelled last week by long-awaited breakthrough Alzheimer’s trial data. Despite major macro headwinds for U.S. stocks, SBIO’s small- to mid-cap (SMID) biotech holdings that focus on later-stage drug trials continued to show their [...] The post SBIO Rallied While Major Indexes Declined Last Week appeared first on ETF Trends .